Innovent Biologics Technology Limited (shanghai R&d Center)

This is the first study in humans testing a new drug called IBI3026 for people with advanced solid tumors that cannot be removed by surgery. The main goals are to find a safe dose and see how the body handles the drug. Researchers will enroll about 300 participants to carefully m…

This study aims to see if a new drug called Tigulixostat works as well or better than the standard drug Febuxostat at lowering uric acid levels in people with gout. About 600 Chinese adults with gout will take one of these drugs for 52 weeks while researchers track their uric aci…

This study is testing an experimental eye injection called IBI302 for people with 'wet' age-related macular degeneration, a major cause of vision loss. The main goal is to see if the treatment helps preserve vision over one year and is safe. About 800 participants will receive th…

This early-stage study is testing a new drug called IBI3032 for weight management. Researchers will first give single doses to healthy volunteers to check safety, then give multiple doses to people with overweight or obesity over four weeks. The main goal is to see how safe the d…